These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15457359)

  • 21. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma.
    Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; lida T; Yagi S; Uemoto S
    Hepatogastroenterology; 2015 Jun; 62(140):933-6. PubMed ID: 26902031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
    Krasnodębski M; Grąt M; Masior Ł; Patkowski W; Krawczyk M
    Ann Transplant; 2015 Feb; 20():70-5. PubMed ID: 25639825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.
    Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ
    J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
    Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.
    Burra P; Germani G; Adam R; Karam V; Marzano A; Lampertico P; Salizzoni M; Filipponi F; Klempnauer JL; Castaing D; Kilic M; Carlis LD; Neuhaus P; Yilmaz S; Paul A; Pinna AD; Burroughs AK; Russo FP
    J Hepatol; 2013 Feb; 58(2):287-96. PubMed ID: 23099188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
    Wu JC; Huang YH; Chau GY; Su CW; Lai CR; Lee PC; Huo TI; Sheen IJ; Lee SD; Lui WY
    J Hepatol; 2009 Nov; 51(5):890-7. PubMed ID: 19747749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of antiviral therapy in the management of hepatocellular carcinoma.
    Guan YS; He Q
    Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
    Kubo S; Tanaka H; Shuto T; Takemura S; Yamamoto T; Kanazawa A; Uenishi T; Tanaka S; Hirohashi K; Nishiguchi S; Kinoshita H
    Surg Today; 2005; 35(3):216-22. PubMed ID: 15772792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group.
    Uenishi T; Nagano H; Marubashi S; Hayashi M; Hirokawa F; Kaibori M; Matsui K; Kubo S
    J Surg Oncol; 2014 Aug; 110(2):176-81. PubMed ID: 24760391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
    JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.
    Hung IF; Wong DK; Poon RT; Fong DY; Chui AH; Seto WK; Fung JY; Chan AC; Yuen JC; Tiu R; Choi O; Lai CL; Yuen MF
    PLoS One; 2016; 11(2):e0148493. PubMed ID: 26901762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma.
    Katsuta E; Tanaka S; Mogushi K; Matsumura S; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Tanaka H; Tanabe M; Arii S
    Am J Surg; 2014 Sep; 208(3):450-6. PubMed ID: 24972857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.